Publicacións (24) Publicacións de IRIA MARIA GOMEZ TOURIÑO

2024

  1. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

    Frontiers in Immunology, Vol. 15

  2. Comment on Lai et al. Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells. Int. J. Mol. Sci. 2023, 24, 16101

    International Journal of Molecular Sciences

  3. Improving colorectal cancer screening programs

    World Journal of Gastroenterology, Vol. 30, Núm. 22, pp. 2849-2851

  4. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

    Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2788-2803

  5. Physiological and pathogenic T cell autoreactivity converge in type 1 diabetes

    Nature Communications , Vol. 15, Núm. 1

  6. Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy

    Cancers, Vol. 16, Núm. 13

  7. The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium

    Diabetologia

2023

  1. Exploring the Effect of Halogenation in a Series of Potent and Selective A2BAdenosine Receptor Antagonists

    Journal of Medicinal Chemistry, Vol. 66, Núm. 1, pp. 890-912

2022

  1. Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 70, Núm. 1

2020

  1. GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells

    Diabetologia, Vol. 63, Núm. 6, pp. 1186-1198

2019

  1. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 5, pp. 6390-6401

2017

  1. Adaptive from innate: Human IFN-g+CD4+ T cells can arise directly from cxcl8-producing recent thymic emigrants in babies and adults

    Journal of Immunology, Vol. 199, Núm. 5, pp. 1696-1705

  2. Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 65, Núm. 4, pp. 275-284

  3. T cell receptor β-chains display abnormal shortening and repertoire sharing in type 1 diabetes

    Nature Communications, Vol. 8, Núm. 1

2016

  1. Discovery of a selective islet peptidome presented by the highest-risk HLA-DQ8trans molecule

    Diabetes, Vol. 65, Núm. 3, pp. 732-741

  2. Hydrophobic CDR3 residues promote the development of self-reactive T cells

    Nature Immunology, Vol. 17, Núm. 8, pp. 946-955

  3. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review

    Journal of Autoimmunity, Vol. 66, pp. 7-16

2015

  1. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

2014

  1. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes

    Diabetes, Vol. 63, Núm. 1, pp. 237-247

  2. Q&A: Françoise Barré-Sinoussi. HIV adversary.

    Nature, Vol. 514, Núm. 7522